Highland Mutual Fund Fund News Today

HHCZX -  USA Fund  

USD 15.64  0.01  0.06%

Highland Fund News module provides quick insight into current market opportunities from investing in Highland LongShort Healthcare. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Highland LongShort fund news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please check Highland LongShort Hype Analysis, Highland LongShort Correlation and Highland LongShort Performance.

Highland Today's Mutual Fund News 

 
Refresh
Highland LongShort mutual fund news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Highland daily returns and investor perception about the current pice of Highland LongShort Healthcare as well as its diversification or hedging effects on your existing portfolios.
six days ago at simplywall.st         
LHC Groups 34 percent CAGR outpaced the companys earnings growth over the same five-year period - Si...
Simply Wall St News at Macroaxis
over two weeks ago at www.equities.com         
LHC falls 0.50 percent for October 8 - Equities.com
Equities News
over three weeks ago at www.equities.com         
LHC falls 1.78 percent for October 4 - Equities.com
Equities News
over a month ago at simplywall.st         
LHC Group, Inc.s Stock Has Shown Weakness Lately But Financial Prospects Look Decent Is The Market W...
Simply Wall St News at Macroaxis
over a month ago at www.equities.com         
LHC falls 1.94 percent on Strong Volume September 16 - Equities.com
Equities News
over a month ago at www.nasdaq.com         
LHC Group to Boost Nationwide Presence With New Buyout - Nasdaq
nasdaq News
over a month ago at seekingalpha.com         
The Schwab U.S Broad Market ETF Is Solid Choice For Diversification - Seeking Alpha
seekingalpha News
over a month ago at finance.yahoo.com         
LHC Group finalizes purchase of Heart of Hospice, with locations in five states - Yahoo Finance
Yahoo News
over two months ago at www.equities.com         
LHC falls 0.56 percent in Light Trading on August 26 - Equities.com
Equities News
over two months ago at www.equities.com         
LHC falls 2.15 percent on Moderate Volume August 18 - Equities.com
Equities News
2 days ago at www.investorsobserver.com         
Should You Buy UnitedHealth Group Inc Stock on Monday - InvestorsObserver
Investors Business Daily at Macroaxis
over a week ago at www.nasdaq.com         
UnitedHealth Group Tops Q3 Earnings and Revenue Estimates - Nasdaq
nasdaq News
over two weeks ago at www.nasdaq.com         
Is UnitedHealth Group Stock Outpacing Its Medical Peers This Year - Nasdaq
nasdaq News
over three weeks ago at www.nasdaq.com         
UnitedHealth Group Dips More Than Broader Markets What You Should Know - Nasdaq
nasdaq News
over three weeks ago at www.equities.com         
Unitedhealth gains 0.45 percent to Close at 400.41 on September 29 - Equities.com
Equities News
over a month ago at www.nasdaq.com         
Has UnitedHealth Group Outpaced Other Medical Stocks This Year - Nasdaq
nasdaq News
over a month ago at www.macroaxis.com         
Unitedhealth exotic insider transaction detected
Macroaxis News
over a month ago at www.zacks.com         
UnitedHealth Group Dips More Than Broader Markets What You Should Know - Zacks.com
zacks News
over a month ago at simplywall.st         
Investing in UnitedHealth Group five years ago would have delivered you a 231 percent gain - Simply ...
Simply Wall St News at Macroaxis
over two months ago at www.nasdaq.com         
UnitedHealth Group Boasts Earnings Price Momentum Should You Buy - Nasdaq
nasdaq News
over three months ago at www.fa-mag.com         
Innovator ETFs Debuts Fund Offering Up To 20 percent Downside Protection - Financial Advisor Magazin...
F
over three months ago at www.etftrends.com         
Access Trends Through Thematic ETFs - ETF Trends
Etftrends at Macroaxis
over three months ago at www.fa-mag.com         
Video - Comparing Vanguard And iShares Socially Responsible ETFs - Financial Advisor Magazine
F
over three months ago at muscatinejournal.com         
Can You Retire a Millionaire With ETFs Alone - Muscatine Journal
M
over six months ago at hickoryrecord.com         
3 ETFs for a Better Earth - Hickory Daily Record
H
over six months ago at finance.yahoo.com         
Best Performing ETFs of Q1 2021 - Yahoo Finance
Yahoo News
over six months ago at www.etftrends.com         
U.S. ETFs Pare Down Their Losses after Fed Statement - ETF Trends
Etftrends at Macroaxis
over six months ago at www.etftrends.com         
Technology and Growth Sectors Drag on U.S. Stock ETFs - ETF Trends
Etftrends at Macroaxis
over six months ago at www.thehindubusinessline.com         
Gold ETFs attract Rs 6,657 crore inflow in 2020 - BusinessLine
H
over six months ago at finance.yahoo.com         
5 ETFs at the Forefront of the Latest Market Rally - Yahoo Finance
Yahoo News
few days ago at www.equities.com         
Abbott Laboratories gains 1.34 percent to Close at 126.72 on October 22 - Equities.com
Equities News
over a week ago at Macroaxis         
Should I rely on Abbott Laboratories management in November 2021?
Macroaxis News
over a week ago at realmoney.thestreet.com         
Can Abbott Labs Get Its Act Together - RealMoney
Thestreet News
over two weeks ago at www.marketwatch.com         
Catalyst Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
marketwatch News
over three weeks ago at www.macroaxis.com         
Acquisition by Patricia Gonzalez of tradable shares of Abbott Laboratories subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.forbes.com         
This Stock Is Likely To Outperform Abbott Laboratories - Forbes
Usa forbes News
over a month ago at simplywall.st         
Abbott Laboratories Stock Is Going Strong Is the Market Following Fundamentals - Simply Wall St
Simply Wall St News at Macroaxis
over a month ago at www.macroaxis.com         
Exercise or conversion by Randel Woodgrift of 1000 shares of Abbott Laboratories subject to Rule 16b...
Macroaxis News
over a month ago at www.fool.com         
Exercise or conversion by Andrea Wainer of 4500 shares of Abbott Laboratories subject to Rule 16b-3
fool News
over a month ago at www.marketwatch.com         
Catalyst Pharmaceuticals Inc. stock rises Monday, still underperforms market - MarketWatch
marketwatch News
few days ago at puck77.com         
Diabetes Software Market SWOT Analysis by 2028 Glooko, Accu-Chek , Tidepool, LifeScan, Inc etc. Puck...
P
over a week ago at www.marketscreener.com         
Roche US FDA approves Roches Tecentriq as adjuvant treatment for certain people with early non-small...
M
over two weeks ago at seekingalpha.com         
Biogen The Price Is Wrong - Seeking Alpha
seekingalpha News
over two weeks ago at finance.yahoo.com         
Should You Invest in Travel Tourism ETFs Now - Yahoo Finance
Yahoo News
over a month ago at finance.yahoo.com         
These OTCQX OTCQB Securities Had the Most Trading Activity in August - Yahoo Finance
Yahoo News
over a month ago at finance.yahoo.com         
Mid-Afternoon Market Update Dow Falls Over 200 Points RenovoRx Shares Spike Higher - Yahoo Finance
Yahoo News
over two months ago at markets.businessinsider.com         
Global 23.6 Bn Asthma Drugs Markets,6 - Introduction of Generic Drugs in Developing Regions Present ...
businessinsider News
over two months ago at www.bioworld.com         
Other news to note for Aug. 10, 2021 2021-08-10 - BioWorld Online
B
over two months ago at markets.businessinsider.com         
Infusion Pump Market worth 20.5 Billion by 2026 - Exclusive Report by MarketsandMarkets - Markets In...
businessinsider News
over three months ago at finance.yahoo.com         
Roche Earnings Preview Heres What to Look For - Yahoo Finance
Yahoo News
few days ago at www.nasdaq.com         
Gilead Sciences Expected to Beat Earnings Estimates What to Know Ahead of Q3 Release - Nasdaq
nasdaq News
over a week ago at www.fool.com         
2 Top Healthcare Stocks That Could Be Bought Out in 2022 - Motley Fool
fool News
over two weeks ago at www.macroaxis.com         
Payment of 1605 shares by Andrew Dickinson of Gilead Sciences subject to Rule 16b-3
Macroaxis News
over three weeks ago at finance.yahoo.com         
ETFs to Play as Merck Shares Surge on COVID Treatment News - Yahoo Finance
Yahoo News
over three weeks ago at www.nasdaq.com         
Gilead Sciences Stock Moves -0.62 percent What You Should Know - Nasdaq
nasdaq News
over a month ago at www.barrons.com         
EV-Charging Stock EVgo Is a Winner for Credit Suisse - Barrons
Barrons News
over a month ago at www.nasdaq.com         
Gilead Sciences, Inc. Ex-Dividend Date Scheduled for September 14, 2021 - Nasdaq
nasdaq News
over a month ago at www.benzinga.com         
A Look Into Gilead Sciences Debt - Benzinga
benzinga news
over two months ago at www.bloomberg.com         
Gilead Wins Reversal of 1.2B Patent Loss to Bristol-Myers - Bloomberg
bloomberg News
over two months ago at www.macroaxis.com         
Exercise or conversion by Wilfong Diane E of 3829 shares of Gilead Sciences subject to Rule 16b-3
Macroaxis News
over six months ago at www.minnpost.com         
What the Boston resisters of the 1760s and 1770s can teach us - MinnPost
M
over six months ago at simplywall.st         
If You Had Bought Oxford Immunotec Globals Shares A Year Ago You Would Be Down 20 percent - Simply W...
Simply Wall St News at Macroaxis
over six months ago at www.nasdaq.com         
3 Top Stocks Under 20 - Nasdaq
nasdaq News
over six months ago at www.nasdaq.com         
Better Buy Vertex Pharmaceuticals vs. Alexion Pharmaceuticals - Nasdaq
nasdaq News
over a year ago at www.mychesco.com         
West Announces Third-Quarter 2020 Results - MyChesCo
M
over a year ago at stockmarketvista.com         
Temporary Healthcare Staffing Market - increasing demand with Industry Professionals Adecco, Almost ...
S
over a year ago at www.macroaxis.com         
Disposition of 4851 shares by Carol Burt of Envision Healthcare subject to Rule 16b-3
Macroaxis News
over a year ago at finance.yahoo.com         
UnitedHealth CEO says COVID-19 pandemic creates uncertainty for 2021 - Yahoo Finance
Yahoo News
over a year ago at simplywall.st         
The Attractive Combination That Could Earn AmerisourceBergen Corporation A Place In Your Dividend Po...
Simply Wall St News at Macroaxis
over a year ago at thedailychronicle.in         
Ambulance Services Industry Industry report indicates Industrial Forecast, Growth Rate Market Share ...
D
few days ago at www.equities.com         
Biohavenmpany gains 2.21 percent for October 22 - Equities.com
Equities News
over a week ago at www.equities.com         
Biohavenmpany falls 0.69 percent for October 19 - Equities.com
Equities News
over two weeks ago at www.nasdaq.com         
Biohaven Q3 Nurtec Preliminary Sales Top Expectations - Nasdaq
nasdaq News
over three weeks ago at www.nasdaq.com         
AbbVies Migraine Prevention Drug Qulipta Gets FDA Nod - Nasdaq
nasdaq News
over a month ago at www.equities.com         
Biohavenmpany falls 1.60 percent to Close at 133.38 on September 24 - Equities.com
Equities News
over a month ago at finance.yahoo.com         
Migraine Pipeline Space Brims with Novel Emerging Therapies with Over 30 Pharma Players Working in t...
Yahoo News
over a month ago at www.nasdaq.com         
Why Is Biohaven Pharmaceutical Holding Company Ltd. Up 21.7 percent Since Last Earnings Report - Nas...
nasdaq News
over two months ago at seekingalpha.com         
UBS hunts crowded trades Most overweight, underweight stocks - Seeking Alpha
seekingalpha News
over two months ago at seekingalpha.com         
Biohaven down 6 percent following Q2 2021 EPS miss, analyst downgrade - Seeking Alpha
seekingalpha News
over three months ago at www.gurufocus.com         
LeJeune Puetz Investment Counsel LLC Buys Amazon.com Inc, iShares ESG Aware MSCI USA Small-Cap ETF, ...
Gurufocus Stories at Macroaxis
few days ago at www.thehindubusinessline.com         
Why you should buy AbbVie Inc. shares - The Hindu BusinessLine - BusinessLine
H
over a week ago at www.marketwatch.com         
AbbVie Inc. stock underperforms Monday when compared to competitors - MarketWatch
marketwatch News
over two weeks ago at seekingalpha.com         
AbbVie Inc. Dissect Its Growth Sustainability And Capital Allocation Like Buffett - Seeking Alpha
seekingalpha News
over two weeks ago at www.nasdaq.com         
Why AbbVie Stock Sank in September - Nasdaq
nasdaq News
over three weeks ago at simplywall.st         
How Many AbbVie Inc. Shares Do Institutions Own - Simply Wall St
Simply Wall St News at Macroaxis
over a month ago at www.nasdaq.com         
3 Relatively Safe Pharma Stocks You Can Buy Right Now - Nasdaq
nasdaq News
over a month ago at www.fool.com         
Is AbbVies 4.9 percent Dividend Yield Safe - Motley Fool
fool News
over a month ago at www.macroaxis.com         
Abbvie exotic insider transaction detected
Macroaxis News
over a month ago at simplywall.st         
Boasting A 53 percent Return On Equity, Is AbbVie Inc. A Top Quality Stock - Simply Wall St
Simply Wall St News at Macroaxis
over a month ago at www.marketwatch.com         
Biogen Inc. stock rises Monday, still underperforms market - MarketWatch
marketwatch News
14 hours ago at Macroaxis         
Should you hold on to your Thermo Fisher position?
Macroaxis News
few days ago at www.entrepreneur.com         
Top Stock Reports for Alphabet, Netflix Thermo Fisher - Entrepreneur
E
over a week ago at www.equities.com         
Thermo Fisher Scientific falls 0.41 percent for October 13 - Equities.com
Equities News
over two weeks ago at www.streetinsider.com         
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - StreetInsider.com
Street Insider News
over three weeks ago at finance.yahoo.com         
Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swind...
Yahoo News
over three weeks ago at www.nasdaq.com         
Thermo Fishers Delta Q IRMS to Back Sustainable Science - Nasdaq
nasdaq News
over a month ago at www.nasdaq.com         
Thermo Fisher Scientific To Present At JP Morgan U.S. All Stars Conference Webcast At 900 AM ET - Na...
nasdaq News
over a month ago at www.marketwatch.com         
Roper Technologies Inc. stock falls Thursday, underperforms market - MarketWatch
marketwatch News
over a month ago at simplywall.st         
Does Thermo Fisher Scientific Deserve A Spot On Your Watchlist - Simply Wall St
Simply Wall St News at Macroaxis
over a month ago at www.nasdaq.com         
Top Stock Reports for Adobe, Thermo Fisher BHP Group - Nasdaq
nasdaq News
over a week ago at www.equities.com         
Takeda Co gains 1.00 percent for October 19 - Equities.com
Equities News
over two weeks ago at www.equities.com         
Takeda Co drops 11.01 percent to Close at 14.31 on October 6 - Equities.com
Equities News
over three weeks ago at www.equities.com         
Takeda Co falls 1.75 percent on Strong Volume September 29 - Equities.com
Equities News
over a month ago at www.equities.com         
Arcturus gains 3.75 percent in Light Trading on September 23 - Equities.com
Equities News
over a month ago at www.equities.com         
Takeda Co falls 0.53 percent for September 20 - Equities.com
Equities News
over a month ago at finance.yahoo.com         
Japan to purchase 150 mln doses of Takeda-produced Novavax vaccines - drugmaker - Yahoo Finance
Yahoo News
over a month ago at finance.yahoo.com         
Moderna says Takeda plans to recall three lots of suspended COVID-19 vaccine - Yahoo Finance
Yahoo News
over two months ago at www.gurufocus.com         
3 Stock Picks for Growth-Oriented Investors - GuruFocus.com
Gurufocus Stories at Macroaxis
over two months ago at finance.yahoo.com         
10 Best Stocks to Buy According to John Paulson - Yahoo Finance
Yahoo News
over three months ago at www.nasdaq.com         
Why DiDi Global Stock Is Plummeting Again Today - Nasdaq
nasdaq News
over six months ago at royalsuttonnews.uk         
Thrombotic Thrombocytopenic Purpura Industry Market Size 2020 Industry Share, Strategies, Growth Ana...
RN
over six months ago at prnewsleader.com         
Shunt Reactor Market Business Insights, Current Trends, Global Industry Analysis by 2025 ABB Ltd, Si...
PN
over six months ago at technoweekly.com         
Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market 2020 Potential growth, attractive v...
T
over six months ago at prnewsleader.com         
Latest News 2020 Synthetic and Bio-Based Biodegradable Plastics Market by Coronavirus-COVID19 Impact...
PN
over six months ago at stockmarketvista.com         
Global Rare Hematology Market Industry Analysis and forecast By Type, Component, Application, and Re...
S
over a year ago at stockmarketvista.com         
Alpha 1 Antitrypsin Deficiency Treatment Market Global Industry Analysis and Forecast 2027 By Treatm...
S
over a year ago at stockmarketvista.com         
Secondary Hyperparathyroidism Drug Market Size, Share, Scope, Growth, Demand and Future Potential of...
S
over a year ago at stockmarketvista.com         
Alpha Galactosidase A Market Plying for Significant Growth During 2026 - Stock Market Vista
S
over a year ago at prnewsleader.com         
Chronic Idiopathic Constipation Treatment Market 2020 Trends, Demand, Revenue, Pre Post COVID-19 Imp...
PN
over a year ago at prnewsleader.com         
BLOOD PLASMA DERIVATIVES Market Report Rising Demand, Growth, Trend, Insights for Coming Years Grifo...
PN
six days ago at www.equities.com         
Natera falls 1.09 percent for October 20 - Equities.com
Equities News
over a week ago at www.equities.com         
Natera gains 1.80 percent on Strong Volume October 13 - Equities.com
Equities News
over two weeks ago at www.equities.com         
Natera falls 2.15 percent on Moderate Volume October 8 - Equities.com
Equities News
over three weeks ago at www.law.com         
Exercise or conversion by Steve Chapman of 2084 shares of Natera subject to Rule 16b-3
L
over three weeks ago at www.macroaxis.com         
Exercise or conversion by Rabinowitz Daniel of 1364 shares of Natera subject to Rule 16b-3
Macroaxis News
over a month ago at www.equities.com         
Exercise or conversion by Rabinowitz Daniel of 893 shares of Natera subject to Rule 16b-3
Equities News
over a month ago at www.macroaxis.com         
Exercise or conversion by Chapman Rowan E of 5500 shares of Natera subject to Rule 16b-3
Macroaxis News
over a month ago at www.equities.com         
Natera falls 0.16 percent to Close at 120.06 on September 14 - Equities.com
Equities News
over a month ago at www.macroaxis.com         
Exercise or conversion by Todd Cozzens of 2733 shares of Natera subject to Rule 16b-3
Macroaxis News
over a month ago at www.equities.com         
Natera gains 1.44 percent to Close at 123.57 on September 2 - Equities.com
Equities News
over two weeks ago at www.valdostadailytimes.com         
FDA Advisory Committee Recommends Use of Investigational Drug Maribavir to Treat Post-Transplant Rec...
V
over two months ago at www.benzinga.com         
Stocks That Hit 52-Week Lows On Monday - Benzinga - Benzinga
benzinga news
over three months ago at www.psychologytoday.com         
Understanding the Anger Impulse and Rage - Psychology Today
P
over three months ago at financialpost.com         
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant Types Supports Efficacy of Ma...
Macroaxis:financialpost news
over three months ago at www.benzinga.com         
U.S. Food Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transpla...
benzinga news
over three months ago at www.sdnews.com         
San Diego Community News Group - weekly briefing la jolla art wine festival to return point loma hig...
SN
over three months ago at www.natlawreview.com         
SCOTUS Hears Minerva Surgical Inc. v. Hologic, Inc. over Assignor Estoppel - The National Law Review
N
over six months ago at www.equities.com         
Minerva Neuroscie gains 0.4 percent for April 23 - Equities.com
Equities News
over six months ago at news.yale.edu         
Monkeys experience the visual world the same way people do - Yale News
.N
over six months ago at www.nasdaq.com         
5 Reasons to Buy Palantir After Its Post-Earnings Plunge - Nasdaq
nasdaq News
a day ago at www.forbes.com         
What To Expect From Mercks Q3 - Forbes
Usa forbes News
over a week ago at www.reuters.com         
US STOCKS-Wall Street ends higher as investors bet on positive earnings season - Reuters
reuters
over three weeks ago at www.macroaxis.com         
Acquisition by Christine Seidman of 209 shares of Merck subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.marketwatch.com         
Merck Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
marketwatch News
over a month ago at seekingalpha.com         
Organon Is Mercks Spin-Off And Your New Dividend Prospect - Seeking Alpha
seekingalpha News
over a month ago at www.etftrends.com         
Blue-Chip Pharmaceuticals Stocks Contend With Political Headwinds - ETF Trends
Etftrends at Macroaxis
over a month ago at www.forbes.com         
Heres Why Pfizer Stock Can Rebound After Falling Nearly 15 percent From Its Peak Last Month - Forbes
Usa forbes News
over a month ago at www.coinspeaker.com         
Top Healthcare Stocks in 2021 - Coinspeaker
Coinspeaker News at Macroaxis
over a month ago at finance.yahoo.com         
Boeing Falls Premarket AMC Entertainment, Match Group Rise - Yahoo Finance
Yahoo News
over a month ago at simplywall.st         
MERCK Kommanditgesellschaft auf Aktiens Stocks On An Uptrend Are Strong Financials Guiding The Marke...
Simply Wall St News at Macroaxis
few days ago at www.macroaxis.com         
Sale by Achenbach Brian of 4450 shares of Mustang Bio
Macroaxis News
over two weeks ago at www.nasdaq.com         
Companies Like Mustang Bio Are In A Position To Invest In Growth - Nasdaq
nasdaq News
over three weeks ago at www.kulr8.com         
Mustang Bio to Participate in Chardans Virtual 5th Annual Genetic Medicines Conference - KULR-TV
K
over a month ago at www.macroaxis.com         
Acquisition by Litchman Manuel Md of 2746 shares of Mustang Bio subject to Rule 16b-3
Macroaxis News
over a month ago at www.globenewswire.com         
Mustang Bio to Participate in Three September 2021 Investor - GlobeNewswire
GN
over a month ago at www.equities.com         
Mustang Bio falls 1.32 percent to Close at 3.00 on September 1 - Equities.com
Equities News
over two months ago at www.equities.com         
Mustang Bio gains 7.49 percent on Strong Volume August 23 - Equities.com
Equities News
over two months ago at www.globenewswire.com         
Mustang Bio Reports Second Quarter 2021 Financial Results - GlobeNewswire
GN
over two months ago at www.equities.com         
Mustang Bio falls 4.11 percent to Close at 2.80 on August 10 - Equities.com
Equities News
over two months ago at www.equities.com         
Mustang Bio gains 5.67 percent on Strong Volume August 6 - Equities.com
Equities News
a day ago at www.nasdaq.com         
Why Anthem has the Fundamental Potential to Keep Delivering on the Long-Term - Nasdaq
nasdaq News
six days ago at www.livemint.com         
Wall St grinds higher on solid healthcare earnings supply woes linger - Mint
L
over a week ago at www.equities.com         
Anthem gains 4.06 percent to Close at 0.71 on October 14 - Equities.com
Equities News
over two weeks ago at www.equities.com         
Anthem gains 2.86 percent to Close at 380.66 on October 7 - Equities.com
Equities News
over three weeks ago at www.macroaxis.com         
Payment of 311 shares by Jeffrey Alter of Anthem subject to Rule 16b-3
Macroaxis News
over three weeks ago at 247wallst.com         
Monday Afternoon Analyst Upgrades and Downgrades Amazon, Best Buy, Lordstown Motors, Nike and More -...
2
over a month ago at www.nasdaq.com         
Why Anthem is a Top Value Stock for the Long-Term - Nasdaq
nasdaq News
over a month ago at www.investing.com         
Better Health Insurance Stock Anthem or Oscar Health By StockNews - Investing.com
Investing News at Macroaxis
over a month ago at www.prnewswire.com         
Anthem, Inc. Launches Four-City Initiative with Heart of America and iHeartMedia to Combat Food Inse...
prnewswire News
over two months ago at simplywall.st         
Heres What Anthem, Inc.s Shareholder Ownership Structure Looks Like - Simply Wall St
Simply Wall St News at Macroaxis
over a week ago at www.equities.com         
Ascendis Pharma AS falls 0.01 percent to Close at 159.99 on October 15 - Equities.com
Equities News
over three weeks ago at www.equities.com         
Ascendis Pharma AS falls 0.36 percent for September 27 - Equities.com
Equities News
over a month ago at www.equities.com         
Ascendis Pharma AS gains 2.46 percent for September 15 - Equities.com
Equities News
over a month ago at www.marketwatch.com         
ADRs End Mostly Higher, Ascendis Pharma Trades Actively - MarketWatch
marketwatch News
over two months ago at www.equities.com         
Ascendis Pharma AS soared 21.05 percent on Strong Volume August 26 - Equities.com
Equities News
over two months ago at markets.businessinsider.com         
Ascendis Pharma earnings preview what Wall Street is expecting - Markets Insider
businessinsider News
over two months ago at www.equities.com         
Ascendis Pharma AS falls 1.33 percent for August 12 - Equities.com
Equities News
over two months ago at www.equities.com         
Ascendis Pharma AS - ADR gains 0.95 percent for August 4 - Equities.com
Equities News
over three months ago at markets.businessinsider.com         
Expert Ratings For Ascendis Pharma Markets Insider - Markets Insider - Markets Insider
businessinsider News
over three months ago at www.equities.com         
Ascendis Pharma AS - ADR falls 2.15 percent for July 14 - Equities.com
Equities News
six days ago at www.equities.com         
Heron falls 1.26 percent for October 20 - Equities.com
Equities News
over two weeks ago at www.nasdaq.com         
Heron Therapeutics Inc Shares Near 52-Week Low - Market Mover - Nasdaq
nasdaq News
over three weeks ago at simplywall.st         
Is Heron Therapeutics Using Too Much Debt - Simply Wall St
Simply Wall St News at Macroaxis
over three weeks ago at www.equities.com         
Heron falls 4.13 percent on Strong Volume September 28 - Equities.com
Equities News
over a month ago at finance.yahoo.com         
Heron Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference - Yahoo Financ...
Yahoo News
over a month ago at www.equities.com         
Heron falls 0.68 percent for September 10 - Equities.com
Equities News
over two months ago at www.equities.com         
Heron falls 1.38 percent in Light Trading on August 26 - Equities.com
Equities News
over two months ago at www.equities.com         
Heron falls 2.13 percent to Close at 10.13 on August 19 - Equities.com
Equities News
over two months ago at www.equities.com         
Heron falls 2. percent to Close at 11.05 on August 13 - Equities.com
Equities News
over two months ago at www.equities.com         
Heron falls 3.48 percent to Close at 11.93 on August 3 - Equities.com
Equities News
few days ago at www.equities.com         
Axonics gains 0. percent on Strong Volume October 22 - Equities.com
Equities News
over two weeks ago at www.equities.com         
Axonics gains 4.44 percent for October 7 - Equities.com
Equities News
over three weeks ago at www.equities.com         
Axonics falls 1.23 percent on Moderate Volume September 30 - Equities.com
Equities News
over a month ago at www.equities.com         
Axonics falls 0.12 percent for September 23 - Equities.com
Equities News
over a month ago at www.macroaxis.com         
Sale by Raymond Cohen of 50000 shares of Axonics
Macroaxis News
over a month ago at www.macroaxis.com         
Exercise or conversion by John Woock of 1557 shares of Axonics subject to Rule 16b-3
Macroaxis News
over two months ago at www.equities.com         
Axonics gains 1.67 percent on Moderate Volume August 27 - Equities.com
Equities News
over two months ago at www.macroaxis.com         
Sale by John Woock of 200 shares of Axonics
Macroaxis News
over two months ago at www.equities.com         
Axonics gains 4.08 percent for August 12 - Equities.com
Equities News
over two months ago at www.marketbeat.com         
Axonics Trading Up 6.6 percent Following Analyst Upgrade - MarketBeat
Marketbeat News
few days ago at www.nasdaq.com         
Bio-Rad to Report Q3 Earnings Whats in the Cards - Nasdaq
nasdaq News
over a week ago at www.gurufocus.com         
Exane Asset Management Buys UB - GuruFocus.com
Gurufocus Stories at Macroaxis
over a week ago at www.equities.com         
Bio-Rad Laboratories gains 1.59 percent to Close at 720.11 on October 14 - Equities.com
Equities News
over two weeks ago at www.directorstalkinterviews.com         
Bio-Rad Laboratories - Consensus Indicates Potential 17.1 percent Upside - DirectorsTalk Interviews
D
over three weeks ago at www.macroaxis.com         
Acquisition by Timothy Ernst of 1013 shares of Bio-Rad Laboratories subject to Rule 16b-3
Macroaxis News
over a month ago at www.equities.com         
Bio-Rad Laboratories gains 1.49 percent to Close at 797.34 on September 23 - Equities.com
Equities News
over a month ago at www.entrepreneur.com         
Bio-Rad Laboratories Is Up 0.05 percent in One Week What You Should Know - Entrepreneur
E
over a month ago at www.marketbeat.com         
Exercise or conversion by Annette Tumolo of 600 shares of Bio-Rad Laboratories subject to Rule 16b-3
Marketbeat News
over a month ago at www.macroaxis.com         
Payment of 248 shares by Timothy Ernst of Bio-Rad Laboratories subject to Rule 16b-3
Macroaxis News
over a month ago at www.nasdaq.com         
What Makes Bio-Rad a Good Fit for Trend Investing - Nasdaq
nasdaq News
2 days ago at www.macroaxis.com         
Sale by Jodi Eddy of 727 shares of Boston Scientific
Macroaxis News
over a week ago at www.equities.com         
Boston Scientific - 5.50 percent PRF CONVERT 01062023 USD 100 - Ser A gains 3.23 percent on Strong V...
Equities News
over two weeks ago at www.equities.com         
Boston Scientific - 5.50 percent PRF CONVERT 01062023 USD 100 - Ser A gains 1.95 percent to Close at...
Equities News
over three weeks ago at www.macroaxis.com         
Exercise or conversion by Brown Vance R of 3393 shares of Boston Scientific subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.equities.com         
Boston Scientific gains 0.50 percent to Close at 43.89 on September 29 - Equities.com
Equities News
over a month ago at www.macroaxis.com         
Exercise or conversion by Michael Mahoney of 66053 shares of Boston Scientific subject to Rule 16b-3
Macroaxis News
over a month ago at www.marketwatch.com         
Teleflex Inc. stock rises Monday, outperforms market - MarketWatch
marketwatch News
over two months ago at www.macroaxis.com         
Sale by Wendy Carruthers of 3322 shares of Boston Scientific
Macroaxis News
over two months ago at www.macroaxis.com         
Sale by Eric Thepaut of 41741 shares of Boston Scientific
Macroaxis News
over two months ago at www.marketwatch.com         
Cooper Cos. stock outperforms competitors on strong trading day - MarketWatch
marketwatch News
few days ago at www.equities.com         
Cigna gains 0.68 percent in Light Trading on October 21 - Equities.com
Equities News
over a week ago at www.gurufocus.com         
Berkshire Bank Buys BTC iShare - GuruFocus.com
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Cigna Corp exotic insider transaction detected
Macroaxis News
over three weeks ago at www.equities.com         
Cigna falls 1.85 percent for September 30 - Equities.com
Equities News
over a month ago at www.equities.com         
Cigna gains 0.71 percent to Close at 203.89 on September 24 - Equities.com
Equities News
over a month ago at www.macroaxis.com         
Cigna Corp exotic insider transaction detected
Macroaxis News
over a month ago at www.marketbeat.com         
Cigna Updates FY 2021 Earnings Guidance - MarketBeat
Marketbeat News
over a month ago at www.macroaxis.com         
Acquisition by Neesha Hathi of 224 shares of Cigna Corp subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Cigna Corp exotic insider transaction detected
Macroaxis News
over two months ago at www.marketwatch.com         
Cigna Sets 2 Billion Accelerated Stock Buyback - MarketWatch
marketwatch News
a day ago at Macroaxis         
Is Centene Corp well-positioned for November economic uncertainties?
Macroaxis News
few days ago at www.equities.com         
Centene gains 1.32 percent in Active Trading on October 21 - Equities.com
Equities News
over a week ago at www.macroaxis.com         
Sale by Richard Gephardt of 3300 shares of Centene Corp
Macroaxis News
over two weeks ago at www.equities.com         
Centene gains 0.56 percent to Close at 64.33 on October 8 - Equities.com
Equities News
over three weeks ago at www.equities.com         
Centene falls 1.50 percent for September 30 - Equities.com
Equities News
over a month ago at www.entrepreneur.com         
Here is Why UnitedHealth Should Grace Your Portfolio - Entrepreneur
E
over a month ago at www.nasdaq.com         
Payment of 3844 shares by Sarah London of Centene Corp subject to Rule 16b-3
nasdaq News
over a month ago at www.marketbeat.com         
Centene PT Lowered to 67.00 at Mizuho - MarketBeat
Marketbeat News
over two months ago at www.macroaxis.com         
Centene Corp exotic insider transaction detected
Macroaxis News
over two months ago at www.marketwatch.com         
Centene Corp. stock underperforms Thursday when compared to competitors - MarketWatch
marketwatch News
few days ago at www.equities.com         
Edwards Lifesciences gains 0.12 percent in Light Trading on October 21 - Equities.com
Equities News
over a week ago at www.macroaxis.com         
Exercise or conversion by Catherine Szyman of 9741 shares of Edwards Lifesciences subject to Rule 16...
Macroaxis News
over two weeks ago at www.macroaxis.com         
Exercise or conversion by Larry Wood of 7830 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
over three weeks ago at finance.yahoo.com         
Is Edwards Lifesciences Corporation Going to Burn These Hedge Funds - Yahoo Finance
Yahoo News
over a month ago at www.macroaxis.com         
Sale by Catherine Szyman of 4665 shares of Edwards Lifesciences
Macroaxis News
over a month ago at www.entrepreneur.com         
3 Strong Buy-the-Dip Candidates in a Volatile Market - Entrepreneur
E
over a month ago at www.macroaxis.com         
Exercise or conversion by Larry Wood of 7830 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
over two months ago at simplywall.st         
Edwards Lifesciences shareholders have earned a 25 percent CAGR over the last five years - Simply Wa...
Simply Wall St News at Macroaxis
over two months ago at simplywall.st         
At US111, Is Edwards Lifesciences Corporation Worth Looking At Closely - Simply Wall St
Simply Wall St News at Macroaxis
over two months ago at www.macroaxis.com         
Exercise or conversion by Donald Bobo of 11050 shares of Edwards Lifesciences subject to Rule 16b-3
Macroaxis News
few days ago at www.equities.com         
EyePoint gains 2.16 percent in Light Trading on October 21 - Equities.com
Equities News
over two weeks ago at www.equities.com         
EyePoint gains 0.10 percent in Light Trading on October 8 - Equities.com
Equities News
over three weeks ago at www.equities.com         
EyePoint falls 5.44 percent for October 4 - Equities.com
Equities News
over three weeks ago at www.equities.com         
EyePoint falls 2.93 percent on Strong Volume September 29 - Equities.com
Equities News
over a month ago at www.equities.com         
EyePoint gains 3.03 percent for September 23 - Equities.com
Equities News
over a month ago at www.equities.com         
EyePoint falls 2.44 percent in Light Trading on September 13 - Equities.com
Equities News
over a month ago at www.benzinga.com         
Why Monopar Therapeutics And EyePoint Pharma Are Trading Higher Today - Benzinga
benzinga news
over two months ago at www.equities.com         
EyePoint falls 2.99 percent on Strong Volume August 19 - Equities.com
Equities News
over two months ago at www.equities.com         
EyePoint gains 0.58 percent to Close at 10.35 on August 13 - Equities.com
Equities News
over two months ago at finance.yahoo.com         
EyePoint Pharmaceuticals, Inc. Released Earnings Last Week And Analysts Lifted Their Price Target To...
Yahoo News
over a week ago at www.nasdaq.com         
Exercise or conversion by John Crowley of 22000 shares of Amicus Therapeutics subject to Rule 16b-3
nasdaq News
over two weeks ago at www.equities.com         
Amicus gains 2.40 percent in Light Trading on October 8 - Equities.com
Equities News
over three weeks ago at www.macroaxis.com         
Acquisition by Burke Whitman of 36111 shares of Amicus Therapeutics subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.equities.com         
Amicus falls 1.20 percent on Moderate Volume September 27 - Equities.com
Equities News
over a month ago at www.equities.com         
Amicus gains 2.49 percent for September 23 - Equities.com
Equities News
over a month ago at www.marketscreener.com         
Amicus Therapeutics Announces Presentations at the 26th International Annual Congress of the World M...
M
over a month ago at www.equities.com         
Amicus falls 3.99 percent for September 14 - Equities.com
Equities News
over a month ago at www.equities.com         
Amicus falls 1.77 percent for September 3 - Equities.com
Equities News
over two months ago at www.equities.com         
Amicus gains 3.68 percent for August 27 - Equities.com
Equities News
over two months ago at www.equities.com         
Amicus gains 0.10 percent in Light Trading on August 19 - Equities.com
Equities News
few days ago at www.nasdaq.com         
Could This Be the Next Blockbuster Indication for Eli Lilly - Nasdaq
nasdaq News
over two weeks ago at catchingnews.com         
ChemoCentryx Inc. Stock Surges Following Approval of TAVNEOS by U.S. FDA - Catching News
CN
over three weeks ago at www.nasdaq.com         
Could AbbVies New Collaboration Be a Blockbuster - Nasdaq
nasdaq News
over a month ago at seekingalpha.com         
AbbVie The FDA Decision On RINVOQ Likely Means Trouble - Seeking Alpha
seekingalpha News
over a month ago at www.bioworld.com         
Abion shares drop in South Korean debut, but listing raises 33M for cancer therapies - BioWorld Onli...
B
over a month ago at www.macroaxis.com         
Acquisition by Krehlik Carrie of 49600 shares of Global Blood subject to Rule 16b-3
Macroaxis News
over two months ago at www.businesswire.com         
Global Cryopreservation Equipment Market Report 2021-2028 - Growing Acceptance for Regenerative Medi...
businesswire News
over two months ago at markets.businessinsider.com         
Diltiazem Market Worth US 369.95 Million at 12.3 percent CAGR of by 2028 - COVID-19 Impact and Globa...
businessinsider News
over two months ago at markets.businessinsider.com         
Increase in Demand for Treatment of Venous Thromboembolism to Boost Global Unfractionated Heparin Ma...
businessinsider News
over two months ago at markets.businessinsider.com         
Hospitals Continue Exhibiting Ultra-low Temperature Freezer Demand, Accounting for 40 percent Sales ...
businessinsider News
2 days ago at www.marketscreener.com         
Humana Expands Footprint in Maryland - marketscreener.com
M
six days ago at www.equities.com         
Humana gains 2.94 percent in Active Trading on October 20 - Equities.com
Equities News
over a week ago at www.nasdaq.com         
3 Leading Telehealth Stocks to Buy in 2021 and Beyond - Nasdaq
nasdaq News
over two weeks ago at www.fool.com         
Why Humana Is Suing Biogen - The Motley Fool
fool News
over three weeks ago at www.macroaxis.com         
Humana exotic insider transaction detected
Macroaxis News
over a month ago at simplywall.st         
Have Humana Inc. Insiders Been Selling Their Stock - Simply Wall St
Simply Wall St News at Macroaxis
over a month ago at invezz.com         
Should you buy CNC shares Humana reportedly wants to buy Centene - Invezz
Invezz News
over a month ago at www.marketbeat.com         
Zacks Analysts Expect Humana Inc. Will Announce Quarterly Sales of 20.91 Billion - MarketBeat
Marketbeat News
over a month ago at simplywall.st         
Are Investors Undervaluing Humana Inc. By 46 - Simply Wall St
Simply Wall St News at Macroaxis
over two months ago at www.nasdaq.com         
Are Investors Undervaluing Humana Inc. By 45 - Nasdaq
nasdaq News
over six months ago at www.macroaxis.com         
Disposition of 21587 shares by Kevin Cordell of Wright Medical subject to Rule 16b-3
Macroaxis News
over six months ago at www.marketbeat.com         
Wright Medical Group Lowered to Sell at BidaskClub - MarketBeat
Marketbeat News
over six months ago at www.reporter.am         
Opportunity on Hot Stock Wright Medical Group N.V. - Armenian Reporter
R
over six months ago at royalsuttonnews.uk         
Large-Joint Reconstructive Implants Market Leading Players Wright Medical Group NV Groupe FH ORTHO c...
RN
over a year ago at thinkcuriouser.com         
Autografts Market Size 2020, Share, Global Industry Analysis and Competitive Landscape - The Think C...
T
over a year ago at rejerusalem.com         
Trauma And Extremities Devices Market COVID-19 Trends, Manufacturers in Globe, Benefits, Opportuniti...
R
over a year ago at crypto-daily.news         
Covid-19 Impact on Joint Replacement Market Global Trends Analysis, Top Manufacturers, Shares, Growt...
CN
over a year ago at simplywall.st         
Wright Medical Group N.V.s Intrinsic Value Is Potentially 75 percent Above Its Share Price - Simply ...
Simply Wall St News at Macroaxis
over a year ago at startupng.com.ng         
Latest News 2020 Titanium-based Alloys Market by Coronavirus-COVID19 Impact Analysis With Top Manufa...
S
over a year ago at scientect.com         
Bone Graft and Substitutes Market Share, Trends, Growth, Sales, Demand, Revenue, Size, Forecast and ...
S
over a week ago at www.marketwatch.com         
Cooper Cos. stock rises Thursday, still underperforms market - MarketWatch
marketwatch News
over three weeks ago at www.equities.com         
Novartis AG falls 0.35 percent on Strong Volume September 28 - Equities.com
Equities News
over a month ago at www.marketwatch.com         
Regeneron Pharmaceuticals Inc. stock falls Monday, still outperforms market - MarketWatch
marketwatch News
over a month ago at www.morningstar.com         
NVS - Morningstar.com
Morningstar News at Macroaxis
over two months ago at www.marketwatch.com         
Regeneron Pharmaceuticals Inc. stock rises Tuesday, outperforms market - MarketWatch
marketwatch News
over three months ago at www.marketwatch.com         
Pfizer Inc. stock rises Wednesday, still underperforms market - MarketWatch
marketwatch News
over three months ago at www.marketwatch.com         
Regeneron Pharmaceuticals Inc. stock rises Friday, outperforms market - MarketWatch
marketwatch News
over three months ago at seekingalpha.com         
World Top 50 Corporate Superstars Include 2 Ideal Dividend Dogs - Seeking Alpha
seekingalpha News
over three months ago at www.nasdaq.com         
Novartis Announces Data on Radioligand Therapy at ASCO - Nasdaq
nasdaq News
over three months ago at ksusentinel.com         
Fibromyalgia Treatment Market 2021 Development Plans of Top Companies Pfizer, Inc., Novartis AG, All...
K
a day ago at newcountry991.com         
2021s 7 Colorado Billionaires Includes Fort Collins Pat Stryker - New Country 99.1
N
over a week ago at www.equities.com         
Stryker gains 2.87 percent on Strong Volume October 14 - Equities.com
Equities News
over two weeks ago at www.marketwatch.com         
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
marketwatch News
over two weeks ago at www.macroaxis.com         
Acquisition by Pierce James Andrew of 3792 shares of Stryker Corp subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.equities.com         
Stryker falls 2.07 percent for September 28 - Equities.com
Equities News
over a month ago at www.nasdaq.com         
Stryker Corp. Shares Approach 52-Week High - Market Mover - Nasdaq
nasdaq News
over a month ago at www.macroaxis.com         
Exercise or conversion by Srikant Datar of 2000 shares of Stryker Corp subject to Rule 16b-3
Macroaxis News
over two months ago at markets.businessinsider.com         
Global 64.5 Billion Medical Equipment Rental and Leasing Markets to 2027 - Markets Insider
businessinsider News
over two months ago at www.marketwatch.com         
Stryker Corp. stock falls Monday, underperforms market - MarketWatch
marketwatch News
over two months ago at www.gurufocus.com         
Motco Buys Stryker Corp, Astra - GuruFocus.com
Gurufocus Stories at Macroaxis
few days ago at www.directorstalkinterviews.com         
Mettler-Toledo International, I - Consensus Indicates Potential 1.0 percent Upside - DirectorsTalk I...
D
over two weeks ago at www.equities.com         
Mettler-Toledo, gains 1.43 percent in Light Trading on October 7 - Equities.com
Equities News
over three weeks ago at simplywall.st         
We Think Mettler-Toledo International Can Manage Its Debt With Ease - Simply Wall St
Simply Wall St News at Macroaxis
over three weeks ago at www.marketwatch.com         
Mettler-Toledo International Inc. stock underperforms Tuesday when compared to competitors - MarketW...
marketwatch News
over a month ago at www.stillwatercurrent.com         
Global Pipettes and Pipette Tips Market 2021 Business Insights Eppendorf, Mettler Toledo, Thermo Fis...
S
over a month ago at www.marketwatch.com         
Mettler-Toledo International Inc. stock falls Thursday, underperforms market - MarketWatch
marketwatch News
over a month ago at finance.yahoo.com         
Stocks Are Getting Pricier as SP Soars, Fewer Firms Do Splits - Yahoo Finance
Yahoo News
over two months ago at www.macroaxis.com         
Exercise or conversion by Oliver Filliol of 7500 shares of Mettler-Toledo International subject to R...
Macroaxis News
over two months ago at www.macroaxis.com         
Sale by Keller Gerry of 124 shares of Mettler-Toledo International
Macroaxis News
over two months ago at www.macroaxis.com         
Exercise or conversion by Robert Spoerry of 1000 shares of Mettler-Toledo International subject to R...
Macroaxis News
six days ago at www.equities.com         
Zogenix gains 0.20 percent on Moderate Volume October 20 - Equities.com
Equities News
over a week ago at www.equities.com         
Zogenix falls 0.64 percent to Close at 15.63 on October 13 - Equities.com
Equities News
over two weeks ago at www.equities.com         
Zogenix gains 0.06 percent on Moderate Volume October 5 - Equities.com
Equities News
over three weeks ago at www.equities.com         
Zogenix falls 2.08 percent on Moderate Volume September 29 - Equities.com
Equities News
over a month ago at www.equities.com         
Zogenix gains 0.71 percent for September 23 - Equities.com
Equities News
over a month ago at www.equities.com         
Zogenix falls 0.73 percent for September 20 - Equities.com
Equities News
over a month ago at www.equities.com         
Zogenix falls 3.24 percent in Light Trading on September 14 - Equities.com
Equities News
over a month ago at www.equities.com         
Zogenix falls 0.95 percent for September 8 - Equities.com
Equities News
over a month ago at www.equities.com         
Zogenix falls 0.47 percent in Light Trading on September 2 - Equities.com
Equities News
over two months ago at www.equities.com         
Zogenix gains 2.10 percent in Light Trading on August 27 - Equities.com
Equities News
few days ago at www.equities.com         
Amarin falls 0.20 percent in Light Trading on October 22 - Equities.com
Equities News
over two weeks ago at www.equities.com         
Amarin gains 1.41 percent in Light Trading on October 8 - Equities.com
Equities News
over two weeks ago at www.wafb.com         
GOTU Shareholder Alert Bronstein, Gewirtz Grossman, LLC Notifies Gaotu Techedu Inc. Shareholders of ...
W
over three weeks ago at www.equities.com         
Amarin falls 0.37 percent in Light Trading on September 27 - Equities.com
Equities News
over a month ago at www.equities.com         
Amarin gains 0.57 percent to Close at 5.30 on September 10 - Equities.com
Equities News
over a month ago at www.equities.com         
Amarin falls 1.81 percent on Moderate Volume August 31 - Equities.com
Equities News
over two months ago at www.equities.com         
Amarin falls 3.25 percent to Close at 5.65 on August 26 - Equities.com
Equities News
over two months ago at www.equities.com         
Amarin falls 0.37 percent on Moderate Volume August 20 - Equities.com
Equities News
over two months ago at www.equities.com         
Amarin rose 14.40 percent to Close at 5.64 on August 12 - Equities.com
Equities News
over two months ago at www.equities.com         
Exercise or conversion by Aaron Berg of 1527 shares of Amarin Corp subject to Rule 16b-3
Equities News
over a week ago at www.macroaxis.com         
Acquisition by Mckenzie Diana of 151 shares of Vertex Pharmaceutic subject to Rule 16b-3
Macroaxis News
over two months ago at www.macroaxis.com         
Payment of 766 shares by Sanna Bastiano of Vertex Pharmaceutic subject to Rule 16b-3
Macroaxis News
over three months ago at www.ownsnap.com         
Cenovus Energy Stock Plunges By 4 percent As It Receives The Rating of Buy Own Snap - Own Snap
O
over three months ago at au.finance.yahoo.com         
Guardians of the Galaxy is more Deus Ex than Avengers - Yahoo Finance Australia
Yahoo News
over three months ago at www.macroaxis.com         
Payment of 311 shares by Bozic Carmen of Vertex Pharmaceutic subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Payment of 766 shares by Sanna Bastiano of Vertex Pharmaceutic subject to Rule 16b-3
Macroaxis News
over three months ago at www.marketscreener.com         
Concert Pharmaceuticals Announces Sale of VX-561 Milestones to Vertex for 32 Million - marketscreene...
M
over three months ago at www.macroaxis.com         
Sale by Sanna Bastiano of 459 shares of Vertex Pharmaceutic
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Alan Garber of 6067 shares of Vertex Pharmaceutic subject to Rule 16b-3
Macroaxis News
over six months ago at www.equities.com         
Vertex Pharmaceutic falls 0.66 percent for April 27 - Equities.com
Equities News
over six months ago at www.cnbc.com         
One stock could reap rewards from the structural changes to the economy, trader says - CNBC
cnbc News
over six months ago at eurowire.co         
Hepatitis A Virus Cellular Receptor 2 Market 2020, Global Research Analysis Report Growth at CAGR Va...
E
over a year ago at www.nasdaq.com         
ANAB, GSK Amend Agreement, BSGM Plunges As COVID-19 Trial Flops, CATB Craters, MRTX Abuzz - Nasdaq
nasdaq News
over a year ago at stockmarketvista.com         
Nausea And Vomiting Treatment Market Size, Share, Scope, Growth, Demand and Future Potential of Indu...
S
over a year ago at stockmarketvista.com         
Global Hepatitis A Virus Cellular Receptor 2 Market 2020 Industry Scenario - Aurigene Discovery Tech...
S
over a year ago at markets.financialcontent.com         
Chemotheraphy Induced Nausea And Vomiting Drugs Market Analysis and Global Outlook 2020-2026 Financi...
M
over a year ago at stockmarketfunda.com         
Blockbuster Oncology Brands Market Size, Sector Industry Report Analysis 2020-2029 - Stock Market Fu...
S
over a year ago at www.macroaxis.com         
Disposition pursuant to a tender of shares in a change of control transaction by Earl Collier of TES...
Macroaxis News
over a year ago at startupng.com.ng         
Current Studies of Global United States Nausea and Vomiting Treatment Market in Demand To Witness a ...
S
over a year ago at marketresearchvista.com         
Global Therapies and Diagnostics for Ovarian Cancer Market 2020 Size, Industry Growth and Forecast t...
M
over a year ago at www.directorstalkinterviews.com         
Quorum Health Corporation - Consensus Indicates Potential 233.3 percent Upside - DirectorsTalk Inter...
D
over a year ago at www.directorstalkinterviews.com         
Quorum Health Corporation - Consensus Indicates Potential 233.3 percent Upside - DirectorsTalk Inter...
D
over a year ago at www.directorstalkinterviews.com         
Quorum Health Corporation - Consensus Indicates Potential 233.3 percent Upside - DirectorsTalk Inter...
D
over a year ago at www.benzinga.com         
Quorum Health Corporation Completes Financial Restructuring, Appoints Joey Jacobs CEO - Benzinga
benzinga news
over a year ago at www.bankruptcompanynews.com         
Quorum Health Corporation Court Rejects Persistent Objections of Equity Holder Mudrick Capital and C...
BN
over a year ago at www.oleantimesherald.com         
Pomerantz LLP Announces Pendency of Class Action Involving Purchasers of Quorum Health Corporation C...
O
over a year ago at www.nashvillepost.com         
Investor calls for slower pace in Quorum Chapter 11 case - Nashville Post
N
over a year ago at uspostnews.com         
Taking an Updated Look at the Data Quorum Health Corporation - US Post News
USpostnews News at Macroaxis
over a year ago at www.fitchratings.com         
Fitch Affirms Tenet Healthcare Corp. at B Outlook Revised to Stable - Fitch Ratings
F
over a year ago at www.macroaxis.com         
Payment of 1236 shares by Mccard Ray Harold Jr of Quorum Health subject to Rule 16b-3
Macroaxis News
There is far too much social signal, news, headlines, and media speculation about Highland LongShort that is available to investors today. That information is available publicly through Highland media outlets and privately through word of mouth or via Highland internal channels. However, regardless of the origin, that massive amount of Highland data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Highland LongShort news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Highland LongShort relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Highland LongShort's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Highland LongShort alpha.
Please check Highland LongShort Hype Analysis, Highland LongShort Correlation and Highland LongShort Performance. Note that the Highland LongShort information on this page should be used as a complementary analysis to other Highland LongShort's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Highland Mutual Fund analysis

When running Highland LongShort price analysis, check to measure Highland LongShort's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Highland LongShort is operating at the current time. Most of Highland LongShort's value examination focuses on studying past and present price action to predict the probability of Highland LongShort's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Highland LongShort's price. Additionally, you may evaluate how the addition of Highland LongShort to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Please note, there is a significant difference between Highland LongShort's value and its price as these two are different measures arrived at by different means. Investors typically determine Highland LongShort value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Highland LongShort's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.